Approach to the Patient: Case Studies in Pediatric Growth Hormone Deficiency and Their Management

被引:4
作者
Henry, Rohan K. [1 ,3 ]
Miller, Bradley S. [2 ]
机构
[1] Ohio State Univ, Nationwide Childrens Hosp, Dept Pediat, Sect Endocrinol,Coll Med, Columbus, OH 43205 USA
[2] Univ Minnesota, MHlth Fairview Masonic Childrens Hosp, Dept Pediat, Div Endocrinol,Med Sch, Minneapolis, MN 55454 USA
[3] Nationwide Childrens Hosp, Sect Endocrinol, 700 Childrens Dr, Columbus, OH 43205 USA
关键词
growth hormone deficiency; GHD; growth hormone; GH; provocation testing; RECOMBINANT HUMAN GH; QUALITY-OF-LIFE; BONE-MINERAL DENSITY; FATTY LIVER-DISEASE; FACTOR-I; CHILDHOOD-ONSET; BODY-COMPOSITION; YOUNG-ADULTS; PROVOCATIVE TESTS; STIMULATION TEST;
D O I
10.1210/clinem/dgad305
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Pathologies attributed to perturbations of the GH/IGF-I axis are among the most common referrals received by pediatric endocrinologists. Aim: In this article, distinctive cased-based presentations are used to provide a practical and pragmatic approach to the management of pediatric growth hormone deficiency (GHD). Cases: We present 4 case vignettes based on actual patients that illustrate (1) congenital GHD, (2) childhood GHD presenting as failure to thrive, (3) childhood GHD presenting in adolescence as growth deceleration, and (4) childhood-onset GHD manifesting as metabolic complications in adolescence. We review patient presentation and a management approach that aims to highlight diagnostic considerations for treatment based on current clinical guidelines, with mention of new therapeutic and diagnostic modalities being used in the field. Conclusion: Pediatric GHD is diverse in etiology and clinical presentation. Timely management has the potential not only to improve growth but can also ameliorate or even mitigate adverse metabolic outcomes, which can be directly attributed to a GH deficient state.
引用
收藏
页码:3009 / 3021
页数:13
相关论文
共 113 条
  • [1] ABRAHAMS JJ, 1991, AM J NEURORADIOL, V12, P155
  • [2] GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults
    Allen, D. B.
    Backeljauw, P.
    Bidlingmaier, M.
    Biller, B. M. K.
    Boguszewski, M.
    Burman, P.
    Butler, G.
    Chihara, K.
    Christiansen, J.
    Cianfarani, S.
    Clayton, P.
    Clemmons, D.
    Cohen, P.
    Darendeliler, F.
    Deal, C.
    Dunger, D.
    Erfurth, E. M.
    Fuqua, J. S.
    Grimberg, A.
    Haymond, M.
    Higham, C.
    Ho, K.
    Hoffman, A. R.
    Hokken-Koelega, A.
    Johannsson, G.
    Juul, A.
    Kopchick, J.
    Lee, P.
    Pollak, M.
    Radovick, S.
    Robison, L.
    Rosenfeld, R.
    Ross, R. J.
    Savendahl, L.
    Saenger, P.
    Sorensen, H. Toft
    Stochholm, K.
    Strasburger, C.
    Swerdlow, A.
    Thorner, M.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2016, 174 (02) : P1 - P9
  • [3] [Anonymous], 2023, DIAGN GROWTH HORM DE
  • [4] [Anonymous], 2021, DIAGN APPR CHILDR AD
  • [5] Effects of up to 15 years of recombinant human GH (rhGH) replacement on bone metabolism in adults with Growth Hormone Deficiency (GHD): The Leiden Cohort Study
    Appelman-Dijkstra, Natasha M.
    Claessen, Kim M. J. A.
    Hamdy, Neveen A. T.
    Pereira, Alberto M.
    Biermasz, Nienke R.
    [J]. CLINICAL ENDOCRINOLOGY, 2014, 81 (05) : 727 - 735
  • [6] Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment
    Attanasio, AF
    Lamberts, SWJ
    Matranga, AMC
    Birkett, MA
    Bates, PC
    Valk, NK
    Hilsted, J
    Bengtsson, BA
    Strasburger, CJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) : 82 - 88
  • [7] Growth hormone assays: current methodologies and their limitations
    Bidlingmaier, Martin
    Strasburger, Christian J.
    [J]. PITUITARY, 2007, 10 (02) : 115 - 119
  • [8] Bidlingmaier Martin, 2010, Handb Exp Pharmacol, P187, DOI 10.1007/978-3-540-79088-4_8
  • [9] The growth hormone-insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders
    Blum, Werner F.
    Alherbish, Abdullah
    Alsagheir, Afaf
    El Awwa, Ahmed
    Kaplan, Walid
    Koledova, Ekaterina
    Savage, Martin O.
    [J]. ENDOCRINE CONNECTIONS, 2018, 7 (06): : R212 - R222
  • [10] Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement
    Boguszewski, Margaret C. S.
    Boguszewski, Cesar L.
    Chemaitilly, Wassim
    Cohen, Laurie E.
    Gebauer, Judith
    Higham, Claire
    Hoffman, Andrew R.
    Polak, Michel
    Yuen, Kevin C. J.
    Alos, Nathalie
    Antal, Zoltan
    Bidlingmaier, Martin
    Biller, Beverley M. K.
    Brabant, George
    Choong, Catherine S. Y.
    Cianfarani, Stefano
    Clayton, Peter E.
    Coutant, Regis
    Cardoso-Demartini, Adriane A.
    Fernandez, Alberto
    Grimberg, Adda
    Gudmundsson, Kolbeinn
    Guevara-Aguirre, Jaime
    Ho, Ken K. Y.
    Horikawa, Reiko
    Isidori, Andrea M.
    Jorgensen, Jens Otto Lunde
    Kamenicky, Peter
    Karavitaki, Niki
    Kopchick, John J.
    Lodish, Maya
    Luo, Xiaoping
    McCormack, Ann, I
    Meacham, Lillian
    Melmed, Shlomo
    Moab, Sogol Mostoufi
    Muller, Hermann L.
    Neggers, Sebastian J. C. M. M.
    Aguiar Oliveira, Manoel H.
    Ozono, Keiichi
    Pennisi, Patricia A.
    Popovic, Vera
    Radovick, Sally
    Savendahl, Lars
    Touraine, Philippe
    van Santen, Hanneke M.
    Johannsson, Gudmundur
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2022, 186 (06) : P35 - P52